Two types of covered self-expanding metal stents were compared in a consecutive series of 57 patients. Stent placement was successful in all patients. No procedure-related deaths were observed. The overall hospital morbidity was 7%. No significant differences in the efficacy of palliation of dysphagia, rate of complications, and survival rates were seen using the two types of stent. An endoscopic reintervention was required in 14% of the patients. Both stents proved to be safely removable in the short term follow-up, and the benefit of temporary insertion was documented in patients with primary oesophageal neoplasms prior to chemotherapy or chemoradiation therapy and in those with anastomotic strictures/leaks. A multidisciplinary strategy, guided by the concept that a stent should not represent the only, definitive treatment modality, may improve the quality of life of patients with advanced oesophageal carcinoma.
Endoprotesi esofagee autoespansibili : studio di confronto tra Ultraflex e Choostent / D. Bona, L. Laface, S. Siboni, M. Schaffer, D. Baldoli, F. Sorba, L. Bonavina, A. Sironi. - In: CHIRURGIA ITALIANA. - ISSN 0009-4773. - 61:5-6(2009 Dec), pp. 641-646.
Endoprotesi esofagee autoespansibili : studio di confronto tra Ultraflex e Choostent
D. Bona;L. Bonavina;A. Sironi
2009
Abstract
Two types of covered self-expanding metal stents were compared in a consecutive series of 57 patients. Stent placement was successful in all patients. No procedure-related deaths were observed. The overall hospital morbidity was 7%. No significant differences in the efficacy of palliation of dysphagia, rate of complications, and survival rates were seen using the two types of stent. An endoscopic reintervention was required in 14% of the patients. Both stents proved to be safely removable in the short term follow-up, and the benefit of temporary insertion was documented in patients with primary oesophageal neoplasms prior to chemotherapy or chemoradiation therapy and in those with anastomotic strictures/leaks. A multidisciplinary strategy, guided by the concept that a stent should not represent the only, definitive treatment modality, may improve the quality of life of patients with advanced oesophageal carcinoma.File | Dimensione | Formato | |
---|---|---|---|
2009_Self-expanding oesophageal stents comparison of Ultraflex and Choostent.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
136.21 kB
Formato
Adobe PDF
|
136.21 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.